Tap Global Group (TAP), an innovative digital finance hub that brings money payments and crypto settlement services together in a single user-friendly app, announced the launch of its Bitcoin Treasury as a Service (“BTaaS”), a comprehensive, institutional-grade platform designed for publicly listed companies adopting Bitcoin as a primary treasury reserve asset.
This new service caters to the growing number of publicly listed companies, both in the UK and globally, implementing Bitcoin-centric treasury strategies. Tap’s BTaaS platform provides a unified solution to the significant operational, security, and execution challenges that companies face when allocating capital to digital assets.
Comment: We can see TAP trying hard to deliver decent newsflow, especially after the latest board appointment. However, this RNS feels 3 months too late, especially as Bitcoin Treasury is currently about as popular as flared trousers – in 1985, or MTV, now. So far, going to AIM, has not helped either, and one still gets the feeling there is a solid seller in the stock anywhere near 3p.
AstraZeneca (AZN) and Amgen’s Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP), a complex epithelial-driven inflammatory condition. Tezspire is the first and only biologic that targets thymic stromal lymphopoietin (TSLP) to be approved for CRSwNP.
Comment: One wonders why a big pharma company wastes time on nasal polyps? Who cares? Presumably, there is more money in this than curing cancer, obesity or degenerative diseases.
Avacta (AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a unique oncology delivery platform, announce that it has raised gross proceeds of approximately £16 million from institutional and high net worth investors by way of a conditional oversubscribed placing at a price of 63 pence. The net proceeds of the Placing provide additional working capital to progress the Company’s R&D programs into 2H 2026 including progressing the faridoxorubicin Phase 1b trial and planned initiation of the FAP-EXd Phase Ia trial. Completion of the Placing will satisfy the remaining conditions to the Amendments to the Convertible Bond terms.
Comment: If one’s memory has not failed one, the last we heard from fans of AVCT, if not the company itself, its tumour-like CLN was all sorted and no fresh funds were needed for the duration. Whether or not this is the case, its R&D seems more expensive than landing someone on Mars.
EDX Medical Group (AQSE:EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announced that the Company has secured funding totalling up to £4 million, through a combination of £2m at a price of 14p and the issue of a new convertible loan note (CLN) agreement for up to £2.0 million to Professor Sir Chris Evans, the Company’s founder and Chief Scientific Officer.
Comment: So far EDX is even better at raising cash and developing cutting edge diagnostics, than it is at selling them and generating cash that way. Hopefully, the development phase will give way to commercialisation early in 2026 at the latest.
The Smarter Web Company (AQUIS: SWC), a London-listed technology company and the UK’s largest publicly traded company holding Bitcoin on its balance sheet, announces that 1,337,000 Ordinary Shares have been placed in accordance with the terms of the Subscription Agreement announced on 04 September 2025. The gross proceeds from the placing of the Subscription Shares will be £1,185,771.81 (before expenses), equivalent to approximately £0.89 per share, and the Company will receive approximately 97% of the proceeds as settlement early this week.
Comment: The message from SWC shareholders currently is sure to be do not raise any more cash, do not dilute any more, and do not buy any more Bitcoin. Just do something, anything to arrest the horrific decline in the shares. This is a situation where doubling down simply will not do.
Amazing AI plc (AQSE: AAI) a global fintech group specialising in online consumer loans and AI finance-related services, announced that Paul Mathieson, CEO, will provide a live investor update presentation via Investor Meet Company on 23 October 2025 at 10:00 BST. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 22 October 2025, 09:00 BST, or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Amazing AI plc via: https://www.investormeetcompany.com/amazing-ai-plc-1/register-investor
Comment: Investors with their backs against the wall in BTC Treasury Stocks such as Smarter Web will be hoping that AAI will show the way in terms of how to successfully deliver a leveraged strategy in BTC / crypto which delivers shareholder value, rather than diluting them to death. Once this is revealed AAI could prove to be the holder of the winning ticket in the space.
B HODL Plc (AQUIS: HODL), the first British company founded for Bitcoin accumulation and revenue generation from the Bitcoin in its treasury, is pleased to announce it has applied to the OTC Markets Group for its Ordinary Shares to be cross traded publicly on the OTCQB Market in the United States. The Board believes that admission to the OTCQB would provide increased visibility and accessibility for U.S. investors, enabling wider participation in the Company’s growth strategy.
Comment: HODL has made its point of differentiation between it and the flailing straight BTC buyers, that it will deliver income on its holdings. This perhaps rather than just listing on the OTCQB could and should be the main focus.
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announce a commercial partnership with Australia based Wellizen. Wellizen is an innovation-driven wellness consumer brand company with a focus on health solutions in nutrition, microbiome and lifestyle wellness. Headquartered in Sydney, Australia, it has operations across New Zealand, Southeast Asia, North America and the Middle East. Wellizen has successfully established its consumer brand THERONOMIC® as a market leader in the precision biotic supplement consumer space.
Comment: So soon after Sweden, we see PBX adding to its footprint, something which should lengthen timeframe the ongoing improvement in the share price which has been delivered over the past year.
Cobra (COBR), a South Australian mineral exploration and development company, is pleased to announce highly favourable preliminary results from flow-sheet optimisation studies aimed at reducing cost and maximising the value of strategic rare earth metals, particularly Dysprosium and Terbium, from its Boland In situ recovery (“ISR”) project in South Australia.
Comment: The rare earths boom is currently so hot at the moment that incidental operational updates from the likes of COBR are almost a sideshow in terms of the strong, ongoing re-rate for the space.
Wellnex Life Limited (WNX) announced that Executive Chairman, Ash Vesali, is today providing the following update to shareholders, and has separately announced the Company’s Q1 FY26 Quarterly Report. He said “I am writing to you following my first few weeks in the role of Executive Chairman to update you on our progress so far and provide more information around our plans. I am acutely aware of the recent share price performance and since joining Wellnex, my primary focus has been on putting a framework in place that can deliver shareholder value through profitable growth. This letter outlines this framework and the specific actions underway to achieve these objectives.”
Comment: The update today is understandably a cross between a mea culpa and an assurance to the market that the company will be on track in terms of a business model that looked not only bright, but straightforward to execute.
GreenX Metals (GRX) said it had uncovered Historical Estimate at Tannenberg. 1940 Historical Estimate of Significant Scale: Historical Estimate from 1940 identifies 728,000 tonnes contained copper (1,605 Mlbs) at an average grade of 2.6% copper in part of Tannenberg Project licence area discovered from original project data archives.
Comment: This announcement is enough to deliver a decent fundamental shot in the arm to GRX, especially given the way the quantum of its find is rather more than the equivalent of finding a few old coins under the sofa cushions.
Prospex Energy (PXEN), the AIM quoted investing company focused on European gas and power projects, informed shareholders that gas production has resumed from the Viura‑1B well in the Viura gas field in northern Spain. The operator of the Viura field, HEYCO Energía Iberia S.L. brought the well back into production on Friday 17 October 2025.
Comment: If there was a potential trigger for a return to form for PXEN, then the announcement of resumed production could be it. That said, there is a long fightback to be delivered here to win back grumpy shareholders.
Genflow Biosciences (GENF) the only publicly listed longevity company in Europe, is pleased to announce that its European patent (No. 22808414.1, Publication No. EP4338267) was officially published in the European Patent Office (EPO) Bulletin on 15 October 2025. The EPO has recognized the patentability of claims of Genflow’s Euro-PCT application, marking a major milestone in the Company’s ongoing intellectual property strategy.
Comment: Things are finally taking shape at everyone’s favourite fountain of youth company, at least if you are a pooch. It helps that biotechs are red hot at the moment as well.
EnergyPathways (EPP), the energy transition company, is pleased to announce that it has given notice to and received consent from the North Sea Transition Authority (“NSTA”) to apply for new hydrogen and natural gas storage licences in the East Irish Sea in support of its flagship MESH project. The Company expects to submit one or more new Gas Storage applications later this month to support its expansion plans for the MESH project – a large-scale long duration energy storage (“LDES”) and decarbonisation project.
Comment: After delivering both triumph and horror to its shareholders over the past couple of years, it is perhaps not surprising that today’s announcement sees the shares relatively flat, as if the company is not merely a binary bet. Glory could still be delivered. However, it could be argued that there are better things to bet on than Ed Miliband, the NSTA (capable of shelving a new 1.1bn barrels discovery in the North Sea) and a skint Labour Government.
Kodal Minerals (KOD), the West African lithium producer and mineral exploration and development company, announce that the first truckloads of lithium spodumene concentrate have left the Bougouni Lithium Project in southern Mali and are completing final customs formalities before transporting to the Cote d’Ivoire port of San Pedro.
Comment: Not just a few kilos, but we have truckloads of the stuff, something which should get the stock even more on the front foot that the initial 15% mark-up that we have seen so far this morning. Surprisingly, KOD is moving even faster than PREM, which is working on producing spodumene well before the next appearance of Halley’s Comet.
Zenith Energy Ltd. (ZEN), the listed international energy production and development company, announce that is fully owned Italian solar energy subsidiary, WESOLAR S.R.L., has signed two separate agreements to acquire two solar energy development projects with a combined capacity of 22 MWp. ZEN said “This growing portfolio already carries tangible market value, which increases as projects mature through successive stages. Given the optimal characteristics and development parameters applied by Zenith, the portfolio could be already sold to professional counterparties, reflecting its strong commercial quality and competitiveness in the market.”
Comment: With the arbitration side of ZEN looking a little brighter, the company is forging ahead on its renewable strategy, and has already acquired a significant portfolio. This on its own could be enough to squeeze the shares higher over the near term.
WeCap (AQSE: WCAP) provided an update on progress of its primary portfolio company, WeShop Holdings Limited who has announced as follows: “Channel Islands, October 20th, 2025 – WeShop Holdings Limited (“WeShop”) , a shoppable social network allowing users in the United Kingdom to shop from hundreds of top retailers whilst also allowing its community to recommend products and services with the potential to earn ownership in the business, today announces that it has publicly filed a registration statement on a Form F-1 with the Securities and Exchange Commission relating to the registration of 12,500,000 WePoints which underpin the ShareBackTM Rewards Plan.
Comment: WCAP is so close to a US listing that you can almost smell it, something which should ensure a squeeze higher in the stock, rather more significant than we have seen thus far.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
